SC-101

· Tianjin ConjuStar Biologics Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for SC-101, covering 2025-07-29 to 2025-09-11. Get the full timeline:

Most recent: Clinical Trial Update: SC-101 in Subjects With Advanced NECTIN4-Amplified Cancers [Phase 2]